Pioneros de la atención cardíaca en el suroeste
Como pioneros de la atención cardíaca en el suroeste, Baylor Scott & White Cardiology Consultants of Texas se esfuerza por brindar a los pacientes con enfermedades cardíacas una atención exhaustiva y compasiva.
Durante casi tres décadas, Baylor Scott & White Cardiology Consultants de Texas ha estado trabajando arduamente para mejorar el nivel de los servicios de cardiología en todo el estado. Nos dedicamos a mejorar el nivel de atención cardiovascular disponible para los pacientes cardíacos participando en ensayos de investigación clínica, lo que nos permite ofrecer a los pacientes atención de calidad a través de tecnologías nuevas y emergentes.

Baylor Scott & White Cardiology Consultants of Texas - Dallas
621 N Hall St Ste 500, Dallas, TX, 75226
- Lunes: 8:00 am - 5:00 pm
- Martes: 8:00 am - 5:00 pm
- Miércoles: 8:00 am - 5:00 pm
- Jueves: 8:00 am - 5:00 pm
- Viernes: 8:00 am - 5:00 pm
- Lunes: 8:30 am - 4:30 pm
- Martes: 8:30 am - 4:30 pm
- Miércoles: 8:30 am - 4:30 pm
- Jueves: 8:30 am - 4:30 pm

Baylor Scott & White Cardiology Consultants of Texas - Greenville
4400 Interstate 30 W Ste 300, Greenville, TX, 75402
- Lunes: 8:30 am - 5:00 pm
- Martes: 8:30 am - 5:00 pm
- Miércoles: 8:30 am - 5:00 pm
- Jueves: 8:30 am - 5:00 pm
- Viernes: 8:30 am - 5:00 pm

Baylor Scott & White Cardiology Consultants of Texas - Mesquite
1575 Interstate 30 , Mesquite, TX, 75150
- Lunes: 8:30 am - 5:00 pm
- Martes: 8:30 am - 5:00 pm
- Miércoles: 8:30 am - 5:00 pm
- Jueves: 8:30 am - 5:00 pm
- Viernes: 8:30 am - 5:00 pm

Baylor Scott & White Cardiology Consultants of Texas - Midway
4431 E US Hwy 287 , Midlothian, TX, 76065
- Lunes: 8:00 am - 5:00 pm
- Martes: 8:00 am - 5:00 pm
- Miércoles: 8:00 am - 5:00 pm
- Jueves: 8:00 am - 5:00 pm
- Viernes: 8:00 am - 5:00 pm

Baylor Scott & White Cardiology Consultants of Texas - Park Cities
9101 N Central Expy Ste 300C, Dallas, TX, 75231
- Lunes: 8:30 am - 5:00 pm
- Martes: 8:30 am - 5:00 pm
- Miércoles: 8:30 am - 5:00 pm
- Jueves: 8:30 am - 5:00 pm
- Viernes: 8:30 am - 5:00 pm

Baylor Scott & White Cardiology Consultants of Texas - Red Oak
301 E Ovilla Rd Ste 100, Red Oak, TX, 75154
- Lunes: 8:00 am - 5:00 pm
- Martes: 8:00 am - 5:00 pm
- Miércoles: 8:00 am - 5:00 pm
- Jueves: 8:00 am - 5:00 pm
- Viernes: 8:00 am - 5:00 pm

Baylor Scott & White Cardiology Consultants of Texas - Terrell
200 N Virginia St , Terrell, TX, 75160

Baylor Scott & White Cardiology Consultants of Texas - Waxahachie
2360 N Interstate 35E Ste 110, Waxahachie, TX, 75165
- Lunes: 8:00 am - 5:00 pm
- Martes: 8:00 am - 5:00 pm
- Miércoles: 8:00 am - 5:00 pm
- Jueves: 8:00 am - 5:00 pm
- Viernes: 8:00 am - 5:00 pm
Seguros aceptados
Baylor Scott & White ha establecido acuerdos con varios tipos de seguros para garantizar que sus necesidades de salud estén cubiertas.
Servicios médicos
- Cardiac catheterization
- Rehabilitación cardiaca
- Cardioversion
- Carotid scan
- Coronary angiogram
- Dobutamine echocardiogram
- Echocardiogram
- Electrocardiogram
- Electrophysiology study
- Exercise echocardiogram (stress echo)
- Exercise stress test
- Exercise thallium
- Holter monitoring
- Nuclear stress test
- Percutaneous transluminal coronary angioplasty
- Permanent pacemaker insertion
- Resting ankle pressures
- Segmental limb pressures
- Signal average electrocardiogram
- Tilt table
- Transesophageal echocardiogram
Pagar la factura
Baylor Scott & White Health se complace en ofrecerle múltiples opciones para pagar su factura. Vea nuestra guía para comprender su estado de cuenta de Baylor Scott & White.
Ofrecemos dos opciones de pago en línea:
- Realiza un pago único sin registrarte seleccionando el Opción "Pagar una factura como invitado".
- Inscríbete o inicie sesión en su cuenta MyBSWHealth para ver los estados de cuenta y los estados de cuenta, configurar un plan de pago o inscribirse en estados de cuenta electrónicos.
Otras opciones de pago:
-
Pago por correo
To ensure that your payment is correctly applied to your account, detach the slip from your Baylor Scott & White billing statement and return the slip with your payment. If paying by check or money order, include your account number on the check or money order.
Please mail the payment to the address listed on your statement.
-
Pagar por teléfono
Los pagos a HTPN se pueden realizar por teléfono con nuestro sistema de pago telefónico automatizado 24 horas al día, los siete días de la semana. Todos los pagos realizados a través del sistema de pago telefónico automatizado se publicarán el siguiente día hábil. Por favor llama 1.866.377.1650.
Si necesita hablar con alguien sobre una factura de un Hospital Baylor Scott & White, nuestro departamento de Atención al Cliente está disponible para recibir pagos por teléfono de lunes a viernes de 8:00 AM a 5:00 PM y puede comunicarse con usted al 1.800.994.0371.
-
Pagar en persona
Los pagos se pueden hacer en persona en el centro donde recibió los servicios.
Asistencia financiera
At Baylor Scott & White Health, we want to be a resource for you and your family. Our team of customer service representatives and financial counselors are here to help you find financial solutions that can help cover your cost of care. We encourage you to speak to a team member before, during or after care is received.
Formularios para pacientes
Para garantizar que su visita a nuestra oficina sea lo más conveniente y eficiente posible, nos complace ofrecer nuestros formularios de registro en línea. El formulario de registro del paciente puede completarse electrónicamente e imprimirse para una mejor legibilidad o completarse manualmente.
Educación del paciente
- Arrhythmia
- Congenital heart defects
- Insuficiencia cardíaca congestiva
- Coronary heart disease
- Health-related links
- Heart muscle disease
- Heart valve disease
- Alta presion sanguinea
- Myocardial infarction
- Fibric acid derivatives
- HMG-COA reductase inhibitors
- Niacin
- Nitroglycerin sublingual or spray
- Ejercicio
- Stop smoking
- Cardiology links
Investigación
For more information about these studies, please call 469.800.7400.
-
Interventional Research
Study Name: CoreValve®
Study Description: According to research, without effective treatment, as many as 50 percent of aortic stenosis patients with sever symptoms die within one year. Baylor Scott & White Heart and Vascular Hospital is currently enrolling patients in the trial. If you feel your patient is at high risk for open heart surgery with aortic stenosis, Baylor will be happy to evaluate if they are eligible for the trial. CoreValve® will be an option for patients who previously had no other options.Location: Baylor Scott & White Heart and Vascular Hospital is one of a select group of clinical sites now participating in a new U.S. clinical trial to evaluate treatment for a common heart disease, severe aortic stenosis. The clinical trial, locally led by primary investigator Robert Stoler, MD, FACC, FSCAI, Co-Medical Director of Cardiology and Medical Director of the Catheterization Lab, is evaluating the Medtronic CoreValve® System as a non-surgical, minimally invasive treatment option for patients with severe aortic stenosis who are at high risk, or are eligible, for open-heart surgery.
Study Name: Endeavor IV
Study Description: To test the safety and effectiveness of the Endeavor stent.Study Name: Syntax
Study Description: To show non-inferior PCI outcomes at 12 months compared with CABG treatment in patients requiring vascularization for 3VD or left main disease.Study Name: Perseus
Study Description: To evaluate the next generation Taxus (Taxus Element) compared to Taxus Express.Study Name: Elite
Study Description: To show a non-inferior safety and efficacy between the Cypher Elite and Cypher Bx Velocity.Study Name: Gravitas
Study Description: To determine whether tailored anti-platelet therapy using the Accumetrics Verify-Now P2Y12 assay reduces MACE after drug-eluting stent implantation.Study Name: ABCD
Study Description: Assess differences in post-discharge satisfaction among patients randomized to receive early discharge following PCI compared with their counterparts who are randomized to an overnight hospital stay in low-risk PCI patients.Study Name: XIENCE
Study Description: A post-market registry.Study Name: Resolute
Study Description: To determine safety and efficacy of the Resolute Zotarolimus-eluting stent.Study Name: Platinum
Study Description: To determine safety and efficacy of the Promus Element stent.Study Name: Coral
Study Description: To answer the question: What is the best treatment for patients who have high blood pressure and renal artery stenosis.Study Name: Educate
Study Description: Dual-Antiplatelet RegistryStudy Name: Rewards-TLX
Study Description: A retrospective study looking at Taxus Liberte' vs. XIENCE.Study Name: Boss Trial
Study Description: Evaluation of sodium bicarbonate to reduce the incidence of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease who are undergoing Angiography.Study Name: CoreValve
Study Description: The CoreValve transcatheter aortic valve system is designed to enable replacement of a diseased aortic valve without open-heart surgery and without surgical removal of the diseased valve.Study Name: Excel
Study Description: To show non-inferior PCI outcomes at 12 months compared with CABG treatment in patients requiring vascularization for 3VD or left main disease.Study Name: Translate-ACS
Study Description: A longitudinal observational acute coronary syndrome (ACS) study. -
Electrophysiology Research
Study Name: aCRT
Study Description: To demonstrate non-inferiority of aCRT algorithm compared to echo-optimized BiV CRT.Study Name: CABANA
Study Description: To compare catheter ablation vs. anti-arrhythmic drug therapy for atrial fibrillation.Study Name: Crystal AF
Study Description: To compare continuous monitoring by implantable loop recorder to standard of care medical treatment in subjects after cryptogenic stroke.Study Name: Duo Flair
Study Description: To test safety and efficacy of Cool Path Ablation system for atrial flutter.Study Name: IRASE
Study Description: To test safety and efficacy of Cool Path Ablation system for paroxysmal atrial fibrillation.Study Name: 4195 Extraction
Study Description: Evaluate safety of 4195 lead removal compared to removal of other Medtronic LV leads.Study Name: SLS
Study Description: To evaluate long-term performance of specific (4195, 4196, etc.) leads and generators.Study Name: 4196
Study Description: New LV lead for Biv pacing designed to provide a non-invasive option to pace the LV lead from a second location post-implant.Study Name: AVERT AF
Study Description: Determine if combination of AVJ ablation followed by BiV pacing improves functional status and exercise capacity compared to rate control meds in patients with chronic AF and depressed EF (single chamber ICD + meds vs. AVJ ablation + CRTD).Study Name: MASH
Study Description: Evaluate ability of Pressure Sensor Defibrillation Lead to meet implant criteria for sensing, pacing, defibrillation and pressure sensing efficacy.Study Name: Optimize RV
Study Description: Comparing safety and effectiveness RV lead placement in septum vs. apex.Study Name: REASSURE
Study Description: Determine safety and efficacy of PPM that incorporates capability to treat atrial arrhythmias ATP and sudden cardiac death.Study Name: Reduce HF
Study Description: Evaluate safety and effectiveness of CHRONICLE ICD system which combines single, dual or BiV device with ability to record and report intracardiac pressure to assess impact of evaluating heart failure related events.Study Name: REINICIAR
Study Description: Assess effect of rate-adaptive pacing in patients with diastolic heart failure and chronotropic incompetence by evaluating functional capacity and quality-or-life changes.Study Name: RIGHT
Study Description: Post-market comparing incidence of VT/VF therapies delivered for SVT episodes in Guidant vs. Medtronic devices.Study Name: 4195 Chronic Performance
Study Description: To evaluate long-term performance of 4195 lead LV lead.Study Name: VEST/PREDICTS
Study Description: VEST: Test hypothesis that non-invasive wearable defibrillator vest will reduce overall mortality in 60 days post-MI in patients with EF<35%- LifeVest = Optimal post MI/CHF Treatment vs. Optimal Post-MI Treatment Online
Predicts: Develop risk stratification tool that predicts occurrence of face ventricular arrhythmias that would result in ICD shocks during 5 years after MI and I.D.'s which patients which benefit from ICD vs. REVEAL monitor.
- ICD in participants who still have LVEF <35% at end of VEST
- REVEAL monitor in those with LVEF>35% at end of VEST